HalfBakedInnovations
Subscribe
Sign in
Home
Notes
Chat
Archive
About
The Biotech Distilled Buy/Sell/Watch List
Updated on February 15, 2026
Dec 22, 2025
•
Biotech Distilled
23
16
Latest
Top
Discussions
Summit Therapeutics (SMMT): Scientific Deep Dive for Ivonescimab and Pipeline Products
A Keytruda Killer or a Regulatory Trap? Unpacking the Tetrabody Science, the Rented Moat, and the FDA’s Geography Problem.
7 hrs ago
•
Biotech Distilled
3
Eton Pharmaceuticals (ETON): Scientific Deep Dive for ALKINDI SPRINKLE and Pipeline Products
Why Boring is Beautiful: A Masterclass in Biological Arbitrage and Rare Disease Execution.
Feb 19
•
Biotech Distilled
4
1
Acumen Pharmaceuticals (ABOS): Scientific Deep Dive for Sabirnetug
Navigating the Dilution Gap for the Next Big Alzheimer’s Bet
Feb 18
•
Biotech Distilled
4
2
Replimune (REPL): Scientific Deep Dive for RP1, RP2, and Pipeline Products
Syncytia, Single-Arm Data, and the Amgen Tax: A Pre-PDUFA Deep Dive into Replimune (REPL)
Feb 17
•
Biotech Distilled
4
1
PMV Pharmaceuticals (PMVP): Scientific Deep Dive for Rezatapopt
Drugging the Guardian of the Genome Before the Cash Runs Out
Feb 16
•
Biotech Distilled
6
3
2
UPDATE: Enanta (ENTA) - Q1 2026 Financial Update
Hints at RSV Partnership & Deep Track Capital Buys In
Feb 14
•
Biotech Distilled
5
1
Update: Ultragenyx (RARE) - Q4 2025 Report
The Dilution Gap Forces a 10% Cut
Feb 14
•
Biotech Distilled
1
1
See all
HalfBakedInnovations
Subscribe
Recommendations
The M&A Hunter
The M&A Hunter
HalfBakedInnovations
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts